14 research outputs found
Synthesis of iron chelates for remediation of iron deficiency in an alkaline and calcareous soil
The present study was aimed to investigate the using iron chelates viz., ferrous glycinate and ferrous citrate for the remediation of iron deficiency in alkaline and calcareous soil. The lab experiment was carried out to study the synthesis of Fe chelates by using organic and amino acid based chelating agents. The Fe chelates were synthesized based on 2:1 molar ratio of chelating agents and metal ions. The synthesized iron chelate was characterized by using Fourier transform infrared spectrophotometer (FT-IR). Finally, the synthesized amino acid and organic acid chelated iron were used to remediate the calcareous soil with black gram as a test crop. Iron content in black gram (above ground mass) tented to fluctuate at different growth stages. The highest shoot iron content of 325, 351 and 347 mg kg-1 at vegetative, flowering and harvest stages were recorded with 1% ferrous glycinate as foliar spraying on 25 and 45 Day after sowing (DAS). The root iron content was also higher in 1% ferrous glycinate as foliar spraying on 25 and 45 DAS. The current investigation affirmed that the utilizing different chelating agents like the ferrous glycinate were powerful than ferrous sulfate, which may build the iron substance and iron take-up of blackgram in various development stages
Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems
Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA
(mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains
scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the
possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single
nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of
broad pharmaceutical application. A core-shell nanostructure is designed with a thermally stabilized
gelatin–pDNA coacervate in its center. Thermal stabilization enhances the core’s colloidal stability
and pDNA shielding effect against nucleases as confirmed by nanoparticle tracking analysis and gel
electrophoresis, respectively. The stabilized, pDNA-loaded core is coated with the cationic peptide
protamine sulfate to enable additional surface-loading with mRNA. The dual-loaded core-shell
system transfects murine dendritic cell line DC2.4 with both fluorescent reporter mRNA and pDNA
simultaneously, showing a transfection efficiency of 61.4 ± 21.6% for mRNA and 37.6 ± 19.45% for
pDNA, 48 h post-treatment, whereas established commercial, experimental, and clinical transfection
reagents fail. Hence, the unique co-transfectional capacity and the negligible cytotoxicity of the
reported system may hold prospects for vaccination among other downstream applications
Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells
Biodegradable polymeric nanoparticles (NP) made from poly (lactid-co-glycolide) acid (PLGA) and chitosan (CS) hold promise as innovative formulations for targeted delivery. Since interactions of such NP with primary human immune cells have not been characterized, yet, here we assessed the effect of PLGA or CS-PLGA NP treatment on human peripheral blood mononuclear cells (PBMC), as well as on monocyte-derived DC (moDC). Amongst PBMC, antigen presenting cells (APC) showed higher uptake of both NP preparations than lymphocytes. Furthermore, moDC internalized CS-PLGA NP more efficiently than PLGA NP, presumably because of receptor-mediated endocytosis. Consequently, CS-PLGA NP were delivered mostly to endosomal compartments, whereas PLGA NP primarily ended up in lysosomes. Thus, CS-PLGA NP confer enhanced delivery to endosomal compartments of APC, offering new therapeutic options to either induce or modulate APC function and to inhibit pathogens that preferentially infect APC
Investment myths and its effect on investment behaviour of young investors influencing socially responsible investment (Sri)
The investment trend gets changes day after day. It became the need of the day to make the investments more sustainable. The concept of Socially Responsible Investment (SRI) became popular in 2017’s. Investors of companies around the world believe and support the fact of the SRI investment strategies to attract national and global investments. This in turn made the inventors consider various non-financial disclosures apart from financial disclosures for investment portfolio creation that affect the investors' traditional investment strategies. This paper covers the current strategy of investment format and pattern in portfolio investment assumptions, beliefs of investment (myths), and its effect on the investment behaviour of young investors
Biocompatible Nanocarrier Fortified with a Dipyridinium-Based Amphiphile for Eradication of Biofilm
Annihilation of bacterial biofilms
is challenging owing to their formidable resistance to therapeutic
antibiotics and thus there is a constant demand for development of
potent antibiofilm agents that can abolish established biofilms. In
the present study, the activity of a dipyridinium-based cationic amphiphile
(<b>compound 1</b>) against established bacterial biofilms and
the subsequent development of a <b>compound 1</b>-loaded nanocarrier
for potential antibiofilm therapy are highlighted. Solution-based
assays and microscopic analysis revealed the antagonistic effect of <b>compound 1</b> on biofilms formed by <i>Staphylococcus aureus</i> MTCC 96 and <i>Pseudomonas aeruginosa</i> MTCC 2488. In
combination studies, <b>compound 1</b> could efficiently potentiate
the action of tobramycin and gentamicin on <i>P. aeruginosa</i> and <i>S. aureus</i> biofilm, respectively. A human serum
albumin (HSA)-based nanocarrier loaded with <b>compound 1</b> was generated, which exhibited sustained release of <b>compound
1</b> at physiological pH. The <b>compound 1</b>-loaded HSA
nanocarrier (C1-HNC) displayed the signature membrane-directed activity
of the amphiphile on target bacteria, efficiently eliminated established
bacterial biofilms, and was observed to be nontoxic to a model human
cell line. Interestingly, <b>compound 1</b> as well as the amphiphile-loaded
HSA nanocarrier could eradicate established <i>S. aureus</i> biofilm from the surface of a Foley’s urinary catheter. On
the basis of its biocompatibility and high antibiofilm activity, it
is conceived that the amphiphile-loaded nanocarrier may hold potential
in antibiofilm therapy
Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems
Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA (mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of broad pharmaceutical application. A core-shell nanostructure is designed with a thermally stabilized gelatin–pDNA coacervate in its center. Thermal stabilization enhances the core’s colloidal stability and pDNA shielding effect against nucleases as confirmed by nanoparticle tracking analysis and gel electrophoresis, respectively. The stabilized, pDNA-loaded core is coated with the cationic peptide protamine sulfate to enable additional surface-loading with mRNA. The dual-loaded core-shell system transfects murine dendritic cell line DC2.4 with both fluorescent reporter mRNA and pDNA simultaneously, showing a transfection efficiency of 61.4 ± 21.6% for mRNA and 37.6 ± 19.45% for pDNA, 48 h post-treatment, whereas established commercial, experimental, and clinical transfection reagents fail. Hence, the unique co-transfectional capacity and the negligible cytotoxicity of the reported system may hold prospects for vaccination among other downstream applications
Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems.
Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA (mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of broad pharmaceutical application. A core-shell nanostructure is designed with a thermally stabilized gelatin-pDNA coacervate in its center. Thermal stabilization enhances the core's colloidal stability and pDNA shielding effect against nucleases as confirmed by nanoparticle tracking analysis and gel electrophoresis, respectively. The stabilized, pDNA-loaded core is coated with the cationic peptide protamine sulfate to enable additional surface-loading with mRNA. The dual-loaded core-shell system transfects murine dendritic cell line DC2.4 with both fluorescent reporter mRNA and pDNA simultaneously, showing a transfection efficiency of 61.4 ± 21.6% for mRNA and 37.6 ± 19.45% for pDNA, 48 h post-treatment, whereas established commercial, experimental, and clinical transfection reagents fail. Hence, the unique co-transfectional capacity and the negligible cytotoxicity of the reported system may hold prospects for vaccination among other downstream applications
Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells.
Biodegradable polymeric nanoparticles (NP) made from poly (lactid-co-glycolide) acid (PLGA) and chitosan (CS) hold promise as innovative formulations for targeted delivery. Since interactions of such NP with primary human immune cells have not been characterized, yet, here we assessed the effect of PLGA or CS-PLGA NP treatment on human peripheral blood mononuclear cells (PBMC), as well as on monocyte-derived DC (moDC). Amongst PBMC, antigen presenting cells (APC) showed higher uptake of both NP preparations than lymphocytes. Furthermore, moDC internalized CS-PLGA NP more efficiently than PLGA NP, presumably because of receptor-mediated endocytosis. Consequently, CS-PLGA NP were delivered mostly to endosomal compartments, whereas PLGA NP primarily ended up in lysosomes. Thus, CS-PLGA NP confer enhanced delivery to endosomal compartments of APC, offering new therapeutic options to either induce or modulate APC function and to inhibit pathogens that preferentially infect APC
Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals.
Pulmonary delivery of nanocarriers for novel antimycobacterial compounds is challenging because the aerodynamic properties of nanomaterials are sub-optimal for such purposes. Here, we report the development of dry powder formulations for nanocarriers containing benzothiazinone 043 (BTZ) or levofloxacin (LVX), respectively. The intricacy is to generate dry powder aerosols with adequate aerodynamic properties while maintaining both nanostructural integrity and compound activity until reaching the deeper lung compartments. Microparticles (MPs) were prepared using vibrating mesh spray drying with lactose and leucine as approved excipients for oral inhalation drug products. MP morphologies and sizes were measured using various biophysical techniques including determination of geometric and aerodynamic mean sizes, X-ray diffraction, and confocal and focused ion beam scanning electron microscopy. Differences in the nanocarriers’ characteristics influenced the MPs’ sizes and shapes, their aerodynamic properties, and, hence, also the fraction available for lung deposition. Spay-dried powders of a BTZ nanosuspension, BTZ-loaded silica nanoparticles (NPs), and LVX-loaded liposomes showed promising respirable fractions, in contrast to zirconyl hydrogen phosphate nanocontainers. While the colloidal stability of silica NPs was improved after spray drying, MPs encapsulating either BTZ nanosuspensions or LVX-loaded liposomes showed the highest respirable fractions and active pharmaceutical ingredient loads. Importantly, for the BTZ nanosuspension, biocompatibility and in vitro uptake by a macrophage model cell line were improved even further after spray drying
Recommended from our members
Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
Pulmonary delivery of nanocarriers for novel antimycobacterial compounds is challenging because the aerodynamic properties of nanomaterials are sub-optimal for such purposes. Here, we report the development of dry powder formulations for nanocarriers containing benzothiazinone 043 (BTZ) or levofloxacin (LVX), respectively. The intricacy is to generate dry powder aerosols with adequate aerodynamic properties while maintaining both nanostructural integrity and compound activity until reaching the deeper lung compartments. Microparticles (MPs) were prepared using vibrating mesh spray drying with lactose and leucine as approved excipients for oral inhalation drug products. MP morphologies and sizes were measured using various biophysical techniques including determination of geometric and aerodynamic mean sizes, X-ray diffraction, and confocal and focused ion beam scanning electron microscopy. Differences in the nanocarriers’ characteristics influenced the MPs’ sizes and shapes, their aerodynamic properties, and, hence, also the fraction available for lung deposition. Spay-dried powders of a BTZ nanosuspension, BTZ-loaded silica nanoparticles (NPs), and LVX-loaded liposomes showed promising respirable fractions, in contrast to zirconyl hydrogen phosphate nanocontainers. While the colloidal stability of silica NPs was improved after spray drying, MPs encapsulating either BTZ nanosuspensions or LVX-loaded liposomes showed the highest respirable fractions and active pharmaceutical ingredient loads. Importantly, for the BTZ nanosuspension, biocompatibility and in vitro uptake by a macrophage model cell line were improved even further after spray drying